Switching to anastrozole plus goserelin versus continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: Preliminary results from a randomized trial

被引：0
|
作者：
Jian-wei, L. [1 ,2 ]
Guangyu, L. [1 ,2 ]
Yajie, J. [1 ,2 ]
Xia, Y. [1 ,2 ]
Zhimin, S. [1 ,2 ]
Da, P. [3 ]
Zefei, J. [4 ]
Dedian, C. [5 ]
Bin, Z. [6 ]
Binghe, X. [7 ]
机构：
[1] Fudan Univ, Shanghai Med Coll, Ctr Canc, Dept Breast Surg, Shanghai 200433, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Inst Canc, Shanghai 200433, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 3, Harbin, Peoples R China
[4] 307 Hosp Peoples Liberat Army, Beijing, Peoples R China
[5] Canc Hosp Yunnan Prov, Kunming, Peoples R China
[6] Canc Hosp Liaoning Prov, Shenyang, Peoples R China
[7] Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)30896-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1948
引用
收藏
页码：S315 / S315
页数：1
相关论文
共 50 条
  • [1] Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial
    Li, Jian-wei
    Liu, Guang-yu
    Ji, Ya-jie
    Yan, Xia
    Pang, Da
    Jiang, Ze-fei
    Chen, De-dian
    Zhang, Bin
    Xu, Bing-he
    Shao, Zhi-ming
    [J]. CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 299 - 307
  • [2] Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Preliminary results of the Italian Tamoxifen Anastrozole trial
    Boccardo, F
    Rubagotti, A
    Puntoni, M
    Guglielmini, P
    Amoroso, D
    Fini, A
    Paladini, G
    Mesiti, M
    Romeo, D
    Rinaldini, M
    Scali, S
    Porpiglia, M
    Benedetto, C
    Restuccia, N
    Buzzi, F
    Franchi, R
    Massidda, B
    Distante, V
    Amadori, D
    Sismondi, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5138 - 5147
  • [3] Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Long term results of the Italian Tamoxifen Anastrozole trial
    Boccardo, F.
    Guglielmini, P.
    Bordonaro, R.
    Fini, A.
    Massidda, B.
    Porpiglia, M.
    Roagna, R.
    Serra, P.
    Orzalesi, L.
    Ucci, G.
    Rubagotti, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (07) : 1546 - 1554
  • [4] Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial
    Boccardo, F.
    Rubagotti, A.
    Guglielmini, P.
    Fini, A.
    Paladini, G.
    Mesiti, M.
    Rinaldini, M.
    Scali, S.
    Porpiglia, M.
    Benedetto, C.
    Restuccia, N.
    Buzzi, F.
    Franchi, R.
    Massidda, B.
    Distante, V.
    Amadori, D.
    Sismondi, P.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : VII10 - VII14
  • [5] Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer
    Bender, Catherine M.
    Sereika, Susan M.
    Brufsky, Adam M.
    Ryan, Christopher M.
    Vogel, Victor G.
    Rastogi, Priya
    Cohen, Susan M.
    Casillo, Frances E.
    Berga, Sarah L.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (06): : 995 - 998
  • [6] Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomized Phase III trial
    Freeston, Sarah
    [J]. WOMENS HEALTH, 2012, 8 (02) : 123 - 124
  • [7] The STAGE Study: A Phase III Comparison of Anastrozole Plus Goserelin with Tamoxifen Plus Goserelin as Pre-Operative Treatments in Premenopausal Breast Cancer Patients
    Sagara, Y.
    Masuda, N.
    Kinoshita, T.
    Iwata, H.
    Nakamura, S.
    Yanagita, Y.
    Nishimura, R.
    Iwase, H.
    Kamigaki, S.
    Takei, H.
    Noguchi, S.
    [J]. CANCER RESEARCH, 2010, 70
  • [8] A randomized trial of goserelin (Zoladex™) plus tamoxifen versus goserelin plus anastrozole (Arimidex™) in pre/perimenopausal patients with hormone dependent advanced breast cancer.
    Milla-Santos, A
    Milla, L
    Portella, J
    Calvo, N
    Rallo, L
    Rodes, E
    Pons, M
    Puig-Gali, M
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S32 - S32
  • [9] Tamoxifen versus anastrozole as adjuvant therapy in early stage breast cancer in premenopausal women on ovarian function suppression: A meta-analysis of randomized clinical trials
    Sidahmed, Shima
    Abdalla, Ahmed
    Kheiri, Babikir
    Bachuwa, Ghassan
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [10] Review of the ATAC study: tamoxifen versus anastrozole in early-stage breast cancer
    Needleman, Sarah J.
    Tobias, Jeffrey S.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (12) : 1871 - 1881
12345